BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Buzás GM. First-line eradication of Helicobacter pylori: Are the standard triple therapies obsolete? A different perspective. World J Gastroenterol 2010; 16(31): 3865-3870 [PMID: 20712046 DOI: 10.3748/wjg.v16.i31.3865]
URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3865.htm
Number Citing Articles
1
Hong Sang Oh, Dong Ho Lee, Ji Yeon Seo, Yu Ri Cho, Nayoung Kim, Sook Hyang Jeoung, Jin Wook Kim, Jin Hyeok Hwang, Young Soo Park, Sang Hyub Lee, Cheol Min Shin, Hyun Jin Cho, Hyun Chae Jung, In Sung Song. Ten‐day sequential therapy is more effective than proton pump inhibitor‐based therapy in Korea: A prospective, randomized studyJournal of Gastroenterology and Hepatology 2012; 27(3): 504 doi: 10.1111/j.1440-1746.2011.06922.x
2
Ji Hyun Lim, Dong Ho Lee, Chiun Choi, Seong Tae Lee, Nayoung Kim, Sook Hyang Jeong, Jin Wook Kim, Jin Hyeok Hwang, Young Soo Park, Sang Hyub Lee, Cheol Min Shin, Hyun Jin Jo, Eun Sun Jang, In sung Song, Hyun Chae Jung. Clinical Outcomes of Two‐Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot StudyHelicobacter 2013; 18(3): 180 doi: 10.1111/hel.12034
3
Dafr Allah Benajah, Mounia Lahbabi, Samia Alaoui, Karima El Rhazi, Mohammed El Abkari, Chakib Nejjari, Afaf Amarti, Bahia Bennani, Mustapha Mahmoud, Sidi Adil Ibrahimi. Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco)Clinics and Research in Hepatology and Gastroenterology 2013; 37(5): 519 doi: 10.1016/j.clinre.2013.02.003
4
A. I. Sharara, A. H. Harb, J. M. Chalhoub. Letter: clarithromycin dose for H. pylori therapy remains unresolved – authors’ replyAlimentary Pharmacology & Therapeutics 2015; 42(5): 632 doi: 10.1111/apt.13323
5
Jacobo Dib, Bethseidy Alvarez, Liskie Mendez, Maria E. Cruz. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospitalArab Journal of Gastroenterology 2013; 14(3): 123 doi: 10.1016/j.ajg.2013.09.001
6
Ethel Zimberg  Chehter. Helicobacter Pylori Treatment with Alternative Drugs: Good and Cheap for Developing Countries Furazolidone-Based Treatment- Omeprazole, Furazolidone and Tetracycline Open-Label Trial in A Developing Country: Why Not?Gastroenterology & Hepatology: Open Access 2014; 1(2) doi: 10.15406/ghoa.2014.01.00011
7
Daniel Pohl, Peter M Keller, Valentine Bordier, Karoline Wagner. Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencingWorld Journal of Gastroenterology 2019; 25(32): 4629-4660 doi: 10.3748/wjg.v25.i32.4629
8
Chao Zhang, Kyle Cleveland, Felice Schnoll-Sussman, Bridget McClure, Michelle Bigg, Prashant Thakkar, Nikolaus Schultz, Manish A. Shah, Doron Betel. Identification of low abundance microbiome in clinical samples using whole genome sequencingGenome Biology 2015; 16(1) doi: 10.1186/s13059-015-0821-z
9
György Miklós Buzás. Helicobacter pylori – 2010Orvosi Hetilap 2010; 151(49): 2003 doi: 10.1556/oh.2010.28982
10
Konrad Egli, Karoline Wagner, Peter M Keller, Lorenz Risch, Martin Risch, Thomas Bodmer. Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pyloriFrontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.596371
11
J. P. Gisbert, X. Calvet. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enoughAlimentary Pharmacology & Therapeutics 2011; 34(11-12): 1255 doi: 10.1111/j.1365-2036.2011.04887.x
12
Sin&eacute;ad M Smith, Colm O&rsquo;Morain, Deirdre McNamara. Antimicrobial susceptibility testing for <italic>Helicobacter pylori</italic> in times of increasing antibiotic resistanceWorld Journal of Gastroenterology 2014; 20(29): 9912-9921 doi: 10.3748/wjg.v20.i29.9912
13
C. A. M. McNulty, G. Lasseter, I. Shaw, T. Nichols, S. D'Arcy, A. J. Lawson, E. Glocker. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?Alimentary Pharmacology & Therapeutics 2012; 35(10): 1221 doi: 10.1111/j.1365-2036.2012.05083.x
14
Francis Lauener, Frank Imkamp, Philippe Lehours, Alice Buissonnière, Lucie Benejat, Reinhard Zbinden, Peter Keller, Karoline Wagner. Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pyloriJournal of Clinical Medicine 2019; 8(1): 53 doi: 10.3390/jcm8010053
15
Angelo Zullo, Carola Severi, Lucy Vannella, Cesare Hassan, Andrea Sbrozzi-Vanni, Bruno Annibale. Role of gastritis pattern on Helicobacter pylori eradicationInternal and Emergency Medicine 2012; 7(6): 517 doi: 10.1007/s11739-011-0730-4
16
Luiz Gonzaga Coelho, Ismael Maguinilk, Schlioma Zaterka, José Miguel Parente, Maria do Carmo Friche Passos, Joaquim Prado P. Moraes-Filho. 3rd BRAZILIAN CONSENSUS ON Helicobacter pyloriArquivos de Gastroenterologia 2013; 50(2): 81 doi: 10.1590/S0004-28032013005000001